Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haruhisa Fukuda

Showing results (71-80 of 144) with videos related to

Pageof 15
Sort By:
BMJ Open|March 31, 2021
National database study of trends in bacteraemia aetiology among children and adults in Japan: a longitudinal observational studyYoshiki Kusama, Kenta Ito, Haruhisa Fukuda, et al.
Journal of Evaluation in Clinical Practice|April 2, 2009
The subjective incremental cost of informed consent and documentation in hospital care: a multicentre questionnaire survey in JapanHaruhisa Fukuda, Yuichi Imanaka, Hiroe Kobuse, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|February 25, 2026
Initial real-world experience with lecanemab prescribing patterns in Japan: The Longevity Improvement & Fair Evidence (LIFE) StudyKengo Kawaguchi, Megumi Maeda, Futoshi Oda, et al.
Journal of Psychiatric Research|April 10, 2024
Incidence of post-COVID psychiatric disorders according to the periods of SARS-CoV-2 variant dominance: The LIFE studyFumiko Murata, Megumi Maeda, Keitaro Murayama, et al.
Journal of Medical Economics|April 28, 2026
Medical costs attributable to obesity and obesity-related health disorders in a Japanese population using JMDC claims databaseTaisuke Kojima, Satoshi Osaga, Toshihiko Aranishi, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 11, 2022
Effectiveness of messenger RNA vaccines against infection with SARS-CoV-2 during the periods of Delta and Omicron variant predominance in Japan: the Vaccine Effectiveness, Networking, and Universal Safety (VENUS) studyWataru Mimura, Chieko Ishiguro, Megumi Maeda, et al.
Open Forum Infectious Diseases|January 2, 2023
Effectiveness of a Third Dose of COVID-19 mRNA Vaccine During the Omicron BA.1- and BA.2-Predominant Periods in Japan: The VENUS StudyWataru Mimura, Chieko Ishiguro, Megumi Maeda, et al.
Digital Health|March 5, 2026
Sleep maintenance efficiency measured by multi-sensor wristband devices and its association with blood pressure: The LIFE studyYubin Sung, Kenichi Goto, Yurina Akeno, et al.
Journal of Evaluation in Clinical Practice|April 1, 2008
Comparisons of risk-adjusted clinical outcomes for patients with aneurysmal subarachnoid haemorrhage across eight teaching hospitals in JapanTatsuro Ishizaki, Yuichi Imanaka, Miho Sekimoto, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|June 28, 2024
Risk of pneumonia-related hospitalization after initiating angiotensin-converting enzyme inhibitors compared with angiotensin II receptor blockers: a retrospective cohort study using LIFE Study dataRyosuke Uemura, Michinari Hieda, Megumi Maeda, et al.
Pageof 15

Showing results (71-80 of 144) with videos related to

Sort By:
Pageof 15
BMJ Open|March 31, 2021
National database study of trends in bacteraemia aetiology among children and adults in Japan: a longitudinal observational studyYoshiki Kusama, Kenta Ito, Haruhisa Fukuda, et al.
Journal of Evaluation in Clinical Practice|April 2, 2009
The subjective incremental cost of informed consent and documentation in hospital care: a multicentre questionnaire survey in JapanHaruhisa Fukuda, Yuichi Imanaka, Hiroe Kobuse, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|February 25, 2026
Initial real-world experience with lecanemab prescribing patterns in Japan: The Longevity Improvement & Fair Evidence (LIFE) StudyKengo Kawaguchi, Megumi Maeda, Futoshi Oda, et al.
Journal of Psychiatric Research|April 10, 2024
Incidence of post-COVID psychiatric disorders according to the periods of SARS-CoV-2 variant dominance: The LIFE studyFumiko Murata, Megumi Maeda, Keitaro Murayama, et al.
Journal of Medical Economics|April 28, 2026
Medical costs attributable to obesity and obesity-related health disorders in a Japanese population using JMDC claims databaseTaisuke Kojima, Satoshi Osaga, Toshihiko Aranishi, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 11, 2022
Effectiveness of messenger RNA vaccines against infection with SARS-CoV-2 during the periods of Delta and Omicron variant predominance in Japan: the Vaccine Effectiveness, Networking, and Universal Safety (VENUS) studyWataru Mimura, Chieko Ishiguro, Megumi Maeda, et al.
Open Forum Infectious Diseases|January 2, 2023
Effectiveness of a Third Dose of COVID-19 mRNA Vaccine During the Omicron BA.1- and BA.2-Predominant Periods in Japan: The VENUS StudyWataru Mimura, Chieko Ishiguro, Megumi Maeda, et al.
Digital Health|March 5, 2026
Sleep maintenance efficiency measured by multi-sensor wristband devices and its association with blood pressure: The LIFE studyYubin Sung, Kenichi Goto, Yurina Akeno, et al.
Journal of Evaluation in Clinical Practice|April 1, 2008
Comparisons of risk-adjusted clinical outcomes for patients with aneurysmal subarachnoid haemorrhage across eight teaching hospitals in JapanTatsuro Ishizaki, Yuichi Imanaka, Miho Sekimoto, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|June 28, 2024
Risk of pneumonia-related hospitalization after initiating angiotensin-converting enzyme inhibitors compared with angiotensin II receptor blockers: a retrospective cohort study using LIFE Study dataRyosuke Uemura, Michinari Hieda, Megumi Maeda, et al.
Pageof 15